FDA news and product notes.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 326
- Publication type:
- Article
Works matching IS 1082801X AND DT 1997 AND VI 32 AND IP 4
Results: 11
1
2
Clinton budget boosts research, squeezes FDA.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 430
- By:
- Publication type:
- Article
3
Abstracts.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 427
- Publication type:
- Article
4
Experience briefs.
- Published in:
- 1997
- By:
- Publication type:
- Case Study
5
How to evaluate the validity and usefulness of pharmacoeconomic literature.
- Published in:
- 1997
- By:
- Publication type:
- Editorial
6
The new non-HIV antivirals and antifungals: Review and assessment for the formulary.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 386
- By:
- Publication type:
- Article
7
Cohort study: Thrombolytics are equally effective, less costly than angioplasty in a community setting.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 376
- Publication type:
- Article
8
Just in from GUSTO-3: Mortality equal for reteplase, rt-PA.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 375
- Publication type:
- Article
9
Perspectives on current, future thrombolytic therapy for acute myocardial infarction.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 364
- By:
- Publication type:
- Article
10
Focus on atorvastatin: An HMG-CoA reductase inhibitor for lowering both elevated LDL cholesterol and triglycerides in hypercholesterolemic patients.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 352
- By:
- Publication type:
- Article
11
News capsules.
- Published in:
- Formulary, 1997, v. 32, n. 4, p. 340
- Publication type:
- Article